Professor of Medicine, University Cincinnati
Infectious Disease
Dr. Carl J. Fichtenbaum, MD
|
|
Give Review
Carl J. Fichtenbaum practices Infectious Disease. He attended University of Missouri - Kansas City School of Medicine. He received 2 awards: "America's Top Doctors" and "CMS Meaningful Use Stage 1 Certification". Carl J. Fichtenbaum, MD is also published. He has 92 publications published. The lastest publication: "Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS.' He is registered with Medicare.
Publications
- Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment: 48-week results from the MODERN study.
- Entrustment and Mapping of Observable Practice Activities for Resident Assessment.
- Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial f...
- Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS ...
- Highly Active Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus Increases CD40 Ligand Expression and IL-12 Production in Cells Ex Vivo.
- Effect of an Emergency Department HIV Testing Program on the Proportion of Emergency Department Patients Who Have Been Tested.
- Preliminary Program Evaluation of Emergency Department HIV Prevention Counseling.
- Comparison of Missed Opportunities for Earlier HIV Diagnosis in 3 Geographically Proximate Emergency Departments.
- Steady-State Pharmacokinetic Interactions of Darunavir/Ritonavir With Lipid-Lowering Agent Rosuvastatin.
- Risk, reasons for refusal, and impact of counseling on consent among ED patients declining HIV screening.
- Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection.
- Frequency of Circulating Regulatory T Cells Increases during Chronic HIV Infection and Is Largely Controlled by Highly Active Antiretroviral Therapy.
- Phase 2a study of the CCR5 monoclonal antibody PRO 140 administered intravenously to HIV-infected adults.
- Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087.
- Does antiretroviral therapy increase or decrease the risk of cardiovascular disease?
- Engagement of the CD4 receptor affects the redistribution of Lck to the immunological synapse in primary T cells: implications for T-cell activation during human immun...
- Metabolic abnormalities associated with HIV infection and antiretroviral therapy.
- Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults.
- Editorial comment: the head bone is connected to the body bone.
- Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186.
- Short-term effect of HAART on blood pressure in HIV-infected individuals.
- Interpreting and implementing the 2006 CDC recommendations for HIV testing in health-care settings.
- The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients.
- Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy.
- Coronary heart disease risk, dyslipidemia, and management in HIV-infected persons.
- CD40 ligand dysregulation in HIV infection: HIV glycoprotein 120 inhibits signaling cascades upstream of CD40 ligand transcription.
- Leptin replacement therapy but not dietary polyunsaturated fatty acid alleviates HIV protease inhibitor-induced dyslipidemia and lipodystrophy in mice.
- Antiretrovirals and cardiovascular disease: is HAART bad for your heart?
- Physician specialization and antiretroviral therapy for HIV.
- An immunocompetent patient with primary Scedosporium apiospermum vertebral osteomyelitis.
- Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons.
- The HIV protease inhibitor ritonavir increases lipoprotein production and has no effect on lipoprotein clearance in mice.
- Ischemic cardiovascular disease in persons with human immunodeficiency virus infection.
- Specialty training and specialization among physicians who treat HIV/AIDS in the United States.
- One size does not fit all.
- Reply to ''Possible bias of ascertainment in assessing chemoprophylaxis for cryptosporidiosis'' by Holmberg and Moorman.
- HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding p...
- I hear you knockin' (but you can't come in): potent new HIV therapies are shutting out opportunistic infections.
- Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease.
- Elevated lactate levels in hospitalized persons with HIV infection.
- Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection.
- In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus.
- Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
- Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.
- A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin B.
- Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.
- Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS.
- Peer-delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers.
- Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8.
- Refractory mucosal candidiasis in patients with human immunodeficiency virus infection.
- The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDS.
- Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome.
- Use of paromomycin for treatment of cryptosporidiosis in patients with AIDS.
- Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome.
- Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study.
- Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma.
- Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system.
- Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection.
- Erythromycin induced cardiovascular toxicity.
- Eosinophilic granuloma of the lung presenting as a solitary pulmonary nodule.
- Review of duodenal diverticula.
- Tentorial traversal by ependymoblastoma.
- Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem.
- Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.
- Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.
- The evaluation and management of dyslipidemia in HIV-infected patients.
- Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of...
- Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108.
- A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: ...
- A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087.
- Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers.
- Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study.
- Treating morphologic and metabolic complications in HIV-infected patients on antiretroviral therapy. A consensus statement of an advisory committee of the Internationa...
- Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection.
- Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals.
- Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.
- Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.
- Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087.
- Osteomyelitis of the skull in early-acquired syphilis: evaluation by MR imaging and CT.
- A novel emergency department based prevention intervention program for people living with HIV: evaluation of early experiences.
- A truvada hypersensitivity reaction simulating abacavir hypersensitivity.
- Contributions to early HIV diagnosis among patients linked to care vary by testing venue.
- Effects of HIV infection and antiretroviral therapy on the heart and vasculature.
- A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis.
- Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients.
- Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy.
- Relationship of self-reported prior testing history to undiagnosed HIV positivity and HIV risk.
- Comparison of emergency department HIV testing data with visit or patient as the unit of analysis.
- Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Cli...
- Fenofibrate in the treatment of dyslipidemia associated with HIV infection.
- High-sensitivity C-reactive protein levels do not decrease with the use of statins in all persons with HIV infection.
Schools
University of Missouri Kansas City Campus
Bridgeport Hospital
YaleWash University St Louis
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
Education
-
Washington University - Barnes-Jewish Hospital -
Yale-New Haven Hospital -
University of Missouri - Kansas City School of Medicine
Hospital
-
University of Cincinnati Medical Center
Drug Facts
| NPI NUMBER | 1073578951 | |
| NPPES Provider LastName | FICHTENBAUM | |
| NPPES Provider FirstName | CARL | |
| NPPES Provider ZIPCode | 452672800 | |
| NPPES Provider State | OH | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 3142.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 251.0 | |
| Percent Opioid Claims | 7.99 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1073578951 |
| Last Name Of The Provider | FICHTENBAUM |
| First Name Of The Provider | CARL |
| View All |
Similar Doctors
|
|
Dr. Rajat Madan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark Kuby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark Bibler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Silvania C. Ng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith Luckett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sonya P. Phillips, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott R. Friedstrom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mayar Al Mohajer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Perlada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rebecca C. Brady, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry S. Bjornson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen M. Kralovic, MD
This Doctor is OpenDoctor Recommended.
|